|
2022
|
Invention
|
Formulations of enzalutamide. This disclosure provides formulations of enzalutamide and their use... |
|
|
Invention
|
Formulations of enzalutamide.
This disclosure provides formulations of enzalutamide and their us... |
|
|
Invention
|
Combination therapy. This disclosure provides a dosage regimen for co-administration of enzalutam... |
|
2021
|
Invention
|
Method for predicting response to breast cancer therapeutic agents and method of treatment of bre... |
|
2020
|
Invention
|
Combination therapy.
This disclosure provides a dosage regimen for co-administration of 4-[7-[6-... |
|
|
Invention
|
Treatment of breast cancer.
The disclosure describes compounds useful for treating breast cancers. |
|
2016
|
Invention
|
Treatment of breast cancer. This disclosure describes the use of one or more compounds that fall ... |
|
|
Invention
|
Treatment of cancer with enzalutamide and a cyp3a4 inhibitor.
This disclosure provides a dosage ... |
|
|
Invention
|
Treatment of cancer using a combination of enzalutamide and a cyp3a4 inducer. This disclosure pro... |
|
2013
|
Invention
|
Formulations of enzalutamide. There is provided herein a formulation of a solid dispersion contai... |
|
|
Invention
|
Specific diarylhydantoin and diarylthiohydantoin compounds. Compositions, such as pharmaceutical ... |
|
|
Invention
|
Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds. Processes are p... |
|
2012
|
Invention
|
Treatment of breast cancer. The disclosure describes the use of one or more compounds that fall w... |
